The BioForum ‘Advancing Challenging Biologics: BsAb, TsAb and RDC/ADC Innovations’, delivered by BioMelbourne Network in collaboration with ProBio, will discuss how the development of complex biologic therapies – including bi-specific and tri-specific antibodies (BsAb and TsAb), ADCs and radiopharmaceutical drug conjugates (RDCs) – is reshaping the therapeutic landscape.

These advanced therapies hold enormous promises for treatment outcomes and patient benefits. However they also present significant and unique challenges from design to manufacturability, scalability, and clinical translation. We’ll bring together experts from across the biologics development spectrum to unpack these challenges and explore future trends. You’ll gain exclusive insights into how innovation, strategy, and collaboration are helping to bring these therapies from lab to life, and how industry leaders navigate these complexities to accelerate the path from pre-clinical development through to commercialisation.

The event promises to be an engaging and insightful forum.